학술논문
Comparison of risankizumab and apremilast for the treatment of adults with moderate plaque psoriasis eligible for systemic therapy: results from a randomized, open-label, assessor-blinded phase IV study (IMMpulse)
Document Type
Article
Author
Source
In: British Journal of Dermatology . (British Journal of Dermatology, November 2023, 189(5):540-552)
Subject
Language
English
ISSN
13652133
00070963
00070963